Targeting cyclin-dependent kinases offers new pathways for cancer therapy

[News]

Cancer is the second leading cause of death in Germany. In the search for new therapeutic approaches that target the uncontrolled growth of tumor cells, a class of enzymes known as cyclin-dependent kinases (CDKs) has come into focus.

More... (https://www.news-medical.net/news/20260824/Targeting-cyclin-dependent-kinases-offers-new-pathways-for-cancer-therapy.aspx)